Esperion Therapeutics, Inc.ESPRNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+15.0%/yr
vs +34.7%/yr prior
5Y CAGR
-3.6%/yr
Recent acceleration
Acceleration
-19.8pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $165.79M | +1.7% |
| 2024 | $163.07M | +14.4% |
| 2023 | $142.52M | +30.7% |
| 2022 | $109.08M | -41.0% |
| 2021 | $184.99M | -7.3% |
| 2020 | $199.62M | +203.1% |
| 2019 | $65.85M | +99.0% |
| 2018 | $33.10M | +54.8% |
| 2017 | $21.38M | +16.9% |
| 2016 | $18.28M | - |